Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03247712 · ClinicalTrials.gov registry record · Phase 1

Neoadjuvant Immunoradiotherapy in Head & Neck Cancer

A Phase 1 study of Head and Neck Cancer and Head and Neck Squamous Cell Carcinoma, sponsored by Providence Health & Services.

Active
Registry status
Phase 1
Development phase
22
Enrollment target
1
Study location

NCT03247712 is a Phase 1 study of Head and Neck Cancer and Head and Neck Squamous Cell Carcinoma that is active but no longer recruiting, run by Providence Health & Services. The registered enrollment target is 22 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03247712, a Phase 1 study of Head and Neck Cancer and Head and Neck Squamous Cell Carcinoma, is active but no longer recruiting, sponsored by Providence Health & Services.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the safety of neoadjuvant immunoradiotherapy as a safe means of down-staging Head and Neck Squamous Cell Carcinoma (HNSCC) prior to surgical resection.

Conditions Studied

Head and Neck Cancer Head and Neck Squamous Cell Carcinoma

Interventions

  • PROCEDURE Surgical Resection
  • DRUG Nivolumab
  • RADIATION Radiation (5 days)
  • RADIATION Radiation (3 days)

Study Locations (1)

Oregon

  • Providence Portland Medical Center - Portland

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2018-01-15
Est. Completion 2026-12
Phase Phase 1

Sponsor

Providence Health & Services

69 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03247712

The ClinicalTrials.gov registry entry for NCT03247712 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (92% lower). The listed sponsor is Providence Health & Services, which has 69 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 4 interventions - of which Surgical Resection is the first listed.

NCT03247712 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT03247712 about?

NCT03247712 is a clinical study titled "Neoadjuvant Immunoradiotherapy in Head & Neck Cancer". The purpose of this study is to test the safety of neoadjuvant immunoradiotherapy as a safe means of down-staging Head and Neck Squamous Cell Carcinoma (HNSCC) prior to surgical resection.

What is the current status of trial NCT03247712?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2018-01-15. Estimated completion is 2026-12.

What conditions does trial NCT03247712 study?

This clinical trial studies the following conditions: Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma.

What interventions are being tested in trial NCT03247712?

The interventions under investigation include: Surgical Resection (PROCEDURE), Nivolumab (DRUG), Radiation (5 days) (RADIATION), Radiation (3 days) (RADIATION).

Who is sponsoring clinical trial NCT03247712?

This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03247712 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Cancer

All registered trials for this condition

Head and Neck Squamous Cell Carcinoma

All registered trials for this condition

Oregon

All trials with a study site in Oregon

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.